🐄Compliance Requirements for HPAI Testing in Agriculture
The Department of Agriculture seeks public comments on information collection requirements related to Highly Pathogenic Avian Influenza (HPAI) in livestock and milk. Regulatory changes mandate testing and reporting for dairy cattle and raw milk to control HPAI's spread, which poses significant risks to the agricultural sector.
Learn More🐾FDA Final Rule on New Animal Drug Regulations Effective May 2025
The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs), abbreviated new animal drug applications (ANADAs), and conditionally approved new animal drug applications (CNADAs) during January, February, and March 2025. The animal drug regulations are also being amended to improve their accuracy and readability.
Learn More🐾FDA Notice on Compounding Animal Drugs from Bulk Substances
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the recordkeeping provisions set forth in Guidance for Industry, GFI #256--Compounding Animal Drugs from Bulk Substances.
Learn More🐄New Import Regulations to Combat Foot-and-Mouth Disease
The Department of Agriculture has proposed a certification requirement for importing farm equipment to prevent the spread of foot-and-mouth disease. Exporters must provide proof of proper cleaning prior to export, affecting compliance processes and restrictions for impacted businesses. Comments on the information collection request are open until March 2025.
Learn More🐴USDA's Equine 2026 Study
In accordance with the Paperwork Reduction Act of 1995, this notice announces the Animal and Plant Health Inspection Service's intention to request the reinstatement of an information collection to conduct the National Animal Health Monitoring System's Equine 2026 Study.
Learn More🐄New Import Regulations for Animals from Panama and Costa Rica
We are advising the public that we have added Panama and Costa Rica to the Animal and Plant Health Inspection Service (APHIS) list maintained on the APHIS website of regions considered affected with screwworm. We took this action because of the confirmation of screwworm in these regions.
Learn More🚫Guatemala and Honduras Added to Screwworm Regulation List
We are advising the public that we have added Guatemala and Honduras to the Animal and Plant Health Inspection Service (APHIS) list maintained on the APHIS website of regions considered affected with screwworm. We took this action because of the confirmation of screwworm in these regions.
Learn More🚫Nicaragua Added to Screwworm List
We are advising the public that we have added Nicaragua to the Animal and Plant Health Inspection Service (APHIS) list maintained on the APHIS website of regions considered affected with screwworm. We took this action because of the confirmation of screwworm in this region.
Learn More🐾FDA Seeks Input on Cannabis-Derived Products in Veterinary Use
The Food and Drug Administration (FDA, the Agency, or we) is soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDPs) in animals, with an emphasis on cannabidiol (CBD) products and general trends associated with those products, including information about: usage trends (e.g., product selection, indications, etc.), quality standards, benefits of use, potential drug interactions, adverse events and safety problems, and toxicological concerns. This information will enhance the Center for Veterinary Medicine's (CVM's) knowledge of potential safety signals associated with these products, in addition to aiding our understanding of veterinarians' experiences related to the use of CDPs for their animal patients.
Learn More🐾FDA Guidance on Type VII Veterinary Master Files for R&D Released
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry (GFI) #260 entitled "Type VII Veterinary Master File for Research and Development and Risk Reviews." This draft guidance, when finalized, will describe FDA's current thinking regarding the use of Type VII Veterinary Master Files (Type VII VMFs). Type VII VMFs are appropriate for research and development of animal cells, tissues, and cell- and tissue-based products (ACTPs), gene therapies, and heritable intentional genomic alterations (IGAs) in animals.
Learn More